Revvity Total Long Term Liabilities 2010-2024 | RVTY
Revvity total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Revvity total long term liabilities for the quarter ending June 30, 2024 were $4.165B, a 16.4% decline year-over-year.
- Revvity total long term liabilities for 2023 were $4.241B, a 18.47% decline from 2022.
- Revvity total long term liabilities for 2022 were $5.202B, a 21.71% decline from 2021.
- Revvity total long term liabilities for 2021 were $6.646B, a 158.32% increase from 2020.
| Revvity Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $4,241 |
| 2022 | $5,202 |
| 2021 | $6,646 |
| 2020 | $2,573 |
| 2019 | $2,962 |
| 2018 | $2,619 |
| 2017 | $2,637 |
| 2016 | $1,520 |
| 2015 | $1,494 |
| 2014 | $1,488 |
| 2013 | $1,349 |
| 2012 | $1,381 |
| 2011 | $1,415 |
| 2010 | $768 |
| 2009 | $933 |
| Revvity Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $4,165 |
| 2024-03-31 | $4,212 |
| 2023-12-31 | $4,241 |
| 2023-09-30 | $4,279 |
| 2023-06-30 | $4,982 |
| 2023-03-31 | $5,041 |
| 2022-12-31 | $5,202 |
| 2022-09-30 | $5,273 |
| 2022-06-30 | $5,979 |
| 2022-03-31 | $6,399 |
| 2021-12-31 | $6,646 |
| 2021-09-30 | $6,796 |
| 2021-06-30 | $3,377 |
| 2021-03-31 | $3,240 |
| 2020-12-31 | $2,573 |
| 2020-09-30 | $2,389 |
| 2020-06-30 | $2,506 |
| 2020-03-31 | $2,895 |
| 2019-12-31 | $2,962 |
| 2019-09-30 | $2,594 |
| 2019-06-30 | $2,985 |
| 2019-03-31 | $2,706 |
| 2018-12-31 | $2,619 |
| 2018-09-30 | $2,603 |
| 2018-06-30 | $2,728 |
| 2018-03-31 | $2,645 |
| 2017-12-31 | $2,637 |
| 2017-09-30 | $1,605 |
| 2017-06-30 | $1,577 |
| 2017-03-31 | $1,531 |
| 2016-12-31 | $1,520 |
| 2016-09-30 | $1,621 |
| 2016-06-30 | $1,545 |
| 2016-03-31 | $1,607 |
| 2015-12-31 | $1,494 |
| 2015-09-30 | $1,423 |
| 2015-06-30 | $1,388 |
| 2015-03-31 | $1,418 |
| 2014-12-31 | $1,488 |
| 2014-09-30 | $1,256 |
| 2014-06-30 | $1,302 |
| 2014-03-31 | $1,336 |
| 2013-12-31 | $1,349 |
| 2013-09-30 | $1,343 |
| 2013-06-30 | $1,388 |
| 2013-03-31 | $1,400 |
| 2012-12-31 | $1,381 |
| 2012-09-30 | $1,365 |
| 2012-06-30 | $1,328 |
| 2012-03-31 | $1,379 |
| 2011-12-31 | $1,415 |
| 2011-09-30 | $581 |
| 2011-06-30 | $1,080 |
| 2011-03-31 | $887 |
| 2010-12-31 | $768 |
| 2010-09-30 | $1,027 |
| 2010-06-30 | $988 |
| 2010-03-31 | $897 |
| 2009-12-31 | $933 |
| 2009-09-30 | $944 |
| 2009-06-30 | $875 |
| 2009-03-31 | $877 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.682B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.658B | 12.24 |
| Cencora (COR) | United States | $49.082B | 18.10 |
| DiDi Global (DIDIY) | China | $23.427B | 0.00 |
| ICON (ICLR) | Ireland | $17.504B | 15.59 |
| Natera (NTRA) | United States | $16.570B | 0.00 |
| Viatris (VTRS) | United States | $15.624B | 4.81 |
| Avantor (AVTR) | United States | $15.178B | 22.75 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.998B | 0.00 |
| Solventum (SOLV) | United States | $12.357B | 0.00 |
| Doximity (DOCS) | United States | $11.372B | 67.31 |
| Medpace Holdings (MEDP) | United States | $11.301B | 31.84 |
| Charles River Laboratories (CRL) | United States | $11.285B | 21.81 |
| HealthEquity (HQY) | United States | $8.756B | 47.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.590B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.202B | 33.53 |
| Life Times (LTH) | United States | $5.139B | 34.01 |
| Sotera Health (SHC) | United States | $4.509B | 24.12 |
| Organon (OGN) | United States | $4.144B | 4.18 |
| Surgery Partners (SGRY) | United States | $3.996B | 44.27 |
| BrightSpring Health Services (BTSG) | United States | $3.489B | 74.22 |
| PACS (PACS) | United States | $3.347B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.580B | 0.00 |
| Concentras Parent (CON) | United States | $2.505B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.471B | 0.00 |
| Premier (PINC) | United States | $2.314B | 11.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.016B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.689B | 0.00 |
| Progyny (PGNY) | United States | $1.540B | 27.08 |
| Pediatrix Medical (MD) | United States | $1.371B | 13.41 |
| Establishment Labs Holdings (ESTA) | $1.266B | 0.00 | |
| CareDx (CDNA) | United States | $1.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.058B | 7.16 |
| Embecta (EMBC) | United States | $0.910B | 6.07 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.809B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.723B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| DocGo (DCGO) | United States | $0.411B | 15.46 |
| Enhabit (EHAB) | United States | $0.403B | 34.83 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.248B | 0.00 |
| ModivCare (MODV) | United States | $0.231B | 12.54 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Biodesix (BDSX) | United States | $0.205B | 0.00 |
| Nutex Health (NUTX) | United States | $0.152B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| So-Young (SY) | China | $0.088B | 21.28 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.10 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |